Home / Data / Women's Health Trial Tracker Women's Health Trial Tracker Women's Health Trial Tracker organizes records from ClinicalTrials.gov API v2 into a static table for transparent comparison. It preserves official source links and dates, marks missing enrichment, and adds deterministic grouping, change, recency, trend, or significance fields only where the documented inputs support them, without recommendations or unsupported claims.
Records 5,000
Last changed 10/10/2026
Update schedule 55 1 * * * UTC
Coverage 05/26/2000–10/09/2026 Record Record Date Vuga Group Change Status Recency Days Research Attention Score Assessment of Breast Cancer Patients Satisfaction and Health Related Quality of Life Outcomes 11/06/2017 OBSERVATIONAL not-comparable 3,260.75 0 High Intensity Focused Ultrasound Treatment of Breast Tumors. BRIFU Study 11/17/2017 INTERVENTIONAL not-comparable 3,249.75 0 Antiviral Prophylaxis and Infant Vaccination to Prevent Perinatal Hepatitis B Infection 11/17/2017 INTERVENTIONAL not-comparable 3,249.75 0 Tazemetostat in Treating Patients With Recurrent Ovarian or Endometrial Cancer 11/21/2017 INTERVENTIONAL not-comparable 3,245.75 0 Bupivacaine vs Placebo for Unilateral Mastectomy Surgical Site Post-operative Pain Control 11/22/2017 INTERVENTIONAL not-comparable 3,244.75 0 An Analysis of Adverse Events and Satisfaction Outcomes of Women Who Underwent Primary and Secondary Breast Augmentation Using Silimed® Breast Implants 11/29/2017 OBSERVATIONAL not-comparable 3,237.75 0 Community-Based Lifestyle Intervention for Diabetes Prevention in Arab Women 12/02/2017 INTERVENTIONAL not-comparable 3,234.75 0 Nurse-Family Partnership Impact Evaluation in South Carolina 12/04/2017 INTERVENTIONAL not-comparable 3,232.75 0 PVX-410 Vaccine Plus Pembrolizumab in HLA-A2+ Metastatic Triple Negative Breast Cancer 12/05/2017 INTERVENTIONAL not-comparable 3,231.75 0 Breast Cancer Study of Preoperative Pembrolizumab + Radiation 12/08/2017 INTERVENTIONAL not-comparable 3,228.75 0 Niraparib in Combination With Trastuzumab in Metastatic HER2+ Breast Cancer 12/11/2017 INTERVENTIONAL not-comparable 3,225.75 0 In Utero Alcoholic Exposure: PlGF, Biomarker of Fetal Brain Lesions 12/13/2017 INTERVENTIONAL not-comparable 3,223.75 0 Breast Cancer Screening: Digital Breast Tomosynthesis Versus Digital 2D Mammography 12/19/2017 INTERVENTIONAL not-comparable 3,217.75 0 Capecitabine 7/7 Schedule With Neratinib in Patients With Metastatic HER2-Positive Breast Cancer 12/19/2017 INTERVENTIONAL not-comparable 3,217.75 0 Trial of Ibrutinib Plus Trastuzumab in HER2-amplified Metastatic Breast Cancer 12/20/2017 INTERVENTIONAL not-comparable 3,216.75 0 Preservation of Ovarian Cortex Tissue in Girls With Turner Syndrome 12/21/2017 INTERVENTIONAL not-comparable 3,215.75 0 Dexmedetomidine Wound Infiltration in Cesarean Section 12/26/2017 INTERVENTIONAL not-comparable 3,210.75 0 International Validation Study of Sentinel Node Biopsy in Early Cervical Cancer 12/29/2017 INTERVENTIONAL not-comparable 3,207.75 0 Long-Term Follow-up Study of Early Stage Breast Cancer Patients Included in GEICAM Studies 01/04/2018 OBSERVATIONAL not-comparable 3,201.75 0 Vaccination Against Human Papillomavirus (HPV) With the 9-valent Vaccine in HIV-positive Women (the Papillon Study) 01/05/2018 INTERVENTIONAL not-comparable 3,200.75 0 Study of IMNN-001 (Also Known as GEN-1) With NACT for Treatment of Ovarian Cancer (OVATION 2) 01/09/2018 INTERVENTIONAL not-comparable 3,196.75 0 Responses to Genetic Risk Modifier Testing Among Women With Pathogenic Variants in Breast Cancer Predisposition Genes 01/10/2018 OBSERVATIONAL not-comparable 3,195.75 0 Gradient-Echo Spectroscopic Imaging Study of Saturated Fat and Breast Cancer 01/17/2018 INTERVENTIONAL not-comparable 3,188.75 0 Effects of Simvastatin on Uterine Leiomyoma Size 01/17/2018 INTERVENTIONAL not-comparable 3,188.75 0 Study to Assess Potential Impairments in Estradiol Augmentation of Gonadotropin Secretion in Polycystic Ovary Syndrome 01/17/2018 INTERVENTIONAL not-comparable 3,188.75 0 Effects of Sucralose on Drug Absorption and Metabolism (The SweetMeds Study) 01/23/2018 INTERVENTIONAL not-comparable 3,182.75 0 Mammography, Early Detection Biomarkers, Risk Assessment, and Imaging Technologies, MERIT Study 01/24/2018 OBSERVATIONAL not-comparable 3,181.75 0 Evaluation And Risk Assessment For Persistent Postsurgical Pain After Breast Surgery 01/24/2018 OBSERVATIONAL not-comparable 3,181.75 0 Perioperative Music Listening on Anxiety, Pain, Analgesia Use and Patient Satisfaction 01/30/2018 INTERVENTIONAL not-comparable 3,175.75 0 Women's IschemiA TRial to Reduce Events In Non-ObstRuctive CAD 01/31/2018 INTERVENTIONAL not-comparable 3,174.75 0 Accelerated iTBS for Post Partum Depression 01/31/2018 INTERVENTIONAL not-comparable 3,174.75 0 Living After a Rare Cancer of the Ovary: Chronic Fatigue, Quality of Life and Late Effects of Chemotherapy 02/01/2018 INTERVENTIONAL not-comparable 3,173.75 0 Study Looking at Biomarkers in Ovarian Cancer 02/05/2018 INTERVENTIONAL not-comparable 3,169.75 0 Study of Radiation Fractionation on Patient Outcomes After Breast REConstruction (FABREC) for Invasive Breast Carcinoma 02/05/2018 INTERVENTIONAL not-comparable 3,169.75 0 Exercise, Fitness and Tumor Profiling in Breast Cancer Patients 02/07/2018 OBSERVATIONAL not-comparable 3,167.75 0 Endocrine Therapy Plus CDK4/6 in First or Second Line for Hormone (SONIA) Receptor Positive Advanced Breast Cancer 02/08/2018 INTERVENTIONAL not-comparable 3,166.75 0 An Early Stress-Reduction Intervention in Patients With Newly Diagnosed Breast Cancer 02/12/2018 INTERVENTIONAL not-comparable 3,162.75 0 Sweden Cancerome Analysis Network - Breast (SCAN-B) Coupled to Psychological Resilience 02/13/2018 OBSERVATIONAL not-comparable 3,161.75 0 Ovarian Function After Use of Various Hemostatic Techniques During Treatment for Endometrioma 02/13/2018 INTERVENTIONAL not-comparable 3,161.75 0 Identification of New Prognostic Markers for Breast Cancer. 02/19/2018 OBSERVATIONAL not-comparable 3,155.75 0 Accelerated Partial Breast Irradiation Study 02/19/2018 INTERVENTIONAL not-comparable 3,155.75 0 Endometrial Cancer Lymphadenectomy Trial 02/19/2018 INTERVENTIONAL not-comparable 3,155.75 0 Comprehensive Lifestyle Change To Prevent Breast Cancer 02/27/2018 INTERVENTIONAL not-comparable 3,147.75 0 The PREDICT Registry: 02/28/2018 OBSERVATIONAL not-comparable 3,146.75 0 Pembrolizumab And Stereotactic Radiosurgery (Srs) Of Selected Brain Metastases In Breast Cancer Patients 02/28/2018 INTERVENTIONAL not-comparable 3,146.75 0 Older Breast Cancer Patients: Risk for Cognitive Decline 03/01/2018 OBSERVATIONAL not-comparable 3,145.75 0 Omission of Radiation in Patients With Her-2 Positive Breast Cancer 03/09/2018 INTERVENTIONAL not-comparable 3,137.75 0 Value of LNG-IUS as Fertility-preserving Treatment of EAH and EC 03/13/2018 INTERVENTIONAL not-comparable 3,133.75 0 Confirmatory Clinical Evaluation of Novilase® Laser Therapy for Focal Destruction of Malignant Breast Tumors 03/13/2018 INTERVENTIONAL not-comparable 3,133.75 0 Individual Approach in Gynecological Cancer Brachytherapy 03/15/2018 INTERVENTIONAL not-comparable 3,131.75 0
Source U.S. National Library of Medicine, ClinicalTrials.gov API v2 · official record · retrieved 10/10/2026 · upstream last modified 10/10/2026
Licence United States government work; public domain unless the source record says otherwise. Source: U.S. National Library of Medicine
Required notice Study records are informational and do not provide diagnosis, treatment advice, or an assessment of individual risk. What we add We compute Vuga Group, Change Status, Recency Days, Research Attention Score using the documented compute method. · methodology